CEO INTERVIEW: 1,000 Users in 72 Hours: How PetVivo's CEO Plans to Ride the AI Pet Care Wave to 8,500 Veterinary Clinics
Mon Jan 26 2026
Join us for an exclusive conversation with John Lai, CEO of PetVivo Holdings, Inc. (NASDAQ: PETV), as we explore how this biomedical device company is positioning itself at the intersection of veterinary therapeutics and the explosive AI-driven preventive pet care revolution.
What You'll Discover:
How Spryng, PetVivo's intra-articular injection for managing lameness and osteoarthritis in dogs and horses, is penetrating the veterinary clinic marketThe strategic significance of the Digital Landia partnership and what AgenticPet's viral adoption (1,000+ beta users in under 72 hours) means for PetVivo's distribution strategyWhy the shift from reactive to preventive pet care creates a massive tailwind for PetVivo's commercial expansion across 8,500+ potential veterinary clinic partnersEXCLUSIVE: Lai's roadmap for scaling beyond the company's lead product into both veterinary and human clinical applicationsHow PetVivo plans to capture value from the convergence of AI diagnostics and therapeutic interventions in the $30+ billion pet healthcare marketLai reveals the company's capital allocation strategy, pipeline priorities, and competitive advantages as veterinary medicine undergoes its biggest transformation in decades. With pet owners demonstrating unprecedented demand for proactive health solutions, discover why PetVivo believes it's positioned to deliver both better patient outcomes and sustainable shareholder returns.
Host: Carmel Fisher
Perfect for: Healthcare investors, veterinary industry professionals, biomedical device sector analysts, and anyone tracking the intersection of AI and animal health.
Key Topics: Veterinary therapeutics, biomedical devices, osteoarthritis treatment, AI-driven diagnostics, preventive care models, veterinary clinic distribution, pet healthcare market dynamics, strategic partnerships
This episode examines how established therapeutic companies can leverage emerging AI platforms to accelerate market penetration and create new revenue opportunities.
Meet the team in person:
DealFlow Discovery Conference,
Borgata Hotel, Casino and Spa (Atlantic City, NJ) - Jan. 28-29, 2026
Disclaimer:
The Harvest podcast is for informational and educational purposes only. The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company or institution mentioned. The content of this podcast does not constitute investment, legal, or tax advice.
Investing in securities involves risk, including the potential loss of principal. Please be aware that the stock market can be volatile and investment values can fluctuate. By listening to this podcast, you agree to not hold the host, guests, producers, or any affiliated companies liable for any investment decisions you make.
Always do your own due diligence and invest responsibly.
More
Join us for an exclusive conversation with John Lai, CEO of PetVivo Holdings, Inc. (NASDAQ: PETV), as we explore how this biomedical device company is positioning itself at the intersection of veterinary therapeutics and the explosive AI-driven preventive pet care revolution. What You'll Discover: How Spryng, PetVivo's intra-articular injection for managing lameness and osteoarthritis in dogs and horses, is penetrating the veterinary clinic marketThe strategic significance of the Digital Landia partnership and what AgenticPet's viral adoption (1,000+ beta users in under 72 hours) means for PetVivo's distribution strategyWhy the shift from reactive to preventive pet care creates a massive tailwind for PetVivo's commercial expansion across 8,500+ potential veterinary clinic partnersEXCLUSIVE: Lai's roadmap for scaling beyond the company's lead product into both veterinary and human clinical applicationsHow PetVivo plans to capture value from the convergence of AI diagnostics and therapeutic interventions in the $30+ billion pet healthcare marketLai reveals the company's capital allocation strategy, pipeline priorities, and competitive advantages as veterinary medicine undergoes its biggest transformation in decades. With pet owners demonstrating unprecedented demand for proactive health solutions, discover why PetVivo believes it's positioned to deliver both better patient outcomes and sustainable shareholder returns. Host: Carmel Fisher Perfect for: Healthcare investors, veterinary industry professionals, biomedical device sector analysts, and anyone tracking the intersection of AI and animal health. Key Topics: Veterinary therapeutics, biomedical devices, osteoarthritis treatment, AI-driven diagnostics, preventive care models, veterinary clinic distribution, pet healthcare market dynamics, strategic partnerships This episode examines how established therapeutic companies can leverage emerging AI platforms to accelerate market penetration and create new revenue opportunities. Meet the team in person: DealFlow Discovery Conference, Borgata Hotel, Casino and Spa (Atlantic City, NJ) - Jan. 28-29, 2026 Disclaimer: The Harvest podcast is for informational and educational purposes only. The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company or institution mentioned. The content of this podcast does not constitute investment, legal, or tax advice. Investing in securities involves risk, including the potential loss of principal. Please be aware that the stock market can be volatile and investment values can fluctuate. By listening to this podcast, you agree to not hold the host, guests, producers, or any affiliated companies liable for any investment decisions you make. Always do your own due diligence and invest responsibly.